Cefoperazone Overview:

Description:
Cefoperazone is a third-generation cephalosporin antibiotic used to treat a wide range of bacterial infections. It works by inhibiting bacterial cell wall synthesis, leading to cell death. Cefoperazone is particularly effective against Gram-negative bacteria and has some activity against Gram-positive organisms.

Available Forms & Strengths:

  1. Injection (IM/IV):
  • 500 mg
  • 250mg
  • 1 g
  • 2 g
  • 3 g
  1. Powder for reconstitution (for injection preparation)

Uses:

  1. Respiratory tract infections (e.g., pneumonia, bronchitis)
  2. Urinary tract infections (UTIs)
  3. Intra-abdominal infections
  4. Skin and soft tissue infections
  5. Septicemia (bloodstream infections)
  6. Gynecological infections (e.g., pelvic inflammatory disease)

Side Effects:

  1. Nausea and vomiting
  2. Diarrhea
  3. Injection site reactions (pain, swelling)
  4. Allergic reactions (rash, itching, anaphylaxis)
  5. Increased liver enzymes
  6. Rare: Prolonged bleeding time due to interference with vitamin K metabolism

Dosage:

  • Adults: 2 to 4 g per day, administered in divided doses every 12 hours.
  • Severe infections: Up to 6 g per day, depending on infection severity.
  • Renal and hepatic impairment: Dosage adjustments may be required for patients with kidney or liver dysfunction.

Contraindications:

  • Hypersensitivity to cefoperazone, other cephalosporins, or any components of the formulation.
  • Cross-sensitivity with penicillins may occur in patients with penicillin allergies.

Warnings:

  1. Hypersensitivity Reactions: Risk of severe allergic reactions, including anaphylaxis, especially in patients with penicillin allergies.
  2. Vitamin K Deficiency: Cefoperazone can interfere with vitamin K metabolism, leading to increased bleeding risk. Vitamin K supplementation may be needed in certain patients, such as those with malnutrition or prolonged use.
  3. Clostridium difficile-associated diarrhea: May occur with prolonged antibiotic use, causing severe diarrhea.
  4. Renal and Hepatic Function: Monitor closely in patients with kidney or liver impairment.
  5. Superinfection: Prolonged use may result in overgrowth of non-susceptible organisms, including fungi.

Special Instructions:

  • Monitor for signs of bleeding, especially in patients at risk of vitamin K deficiency (e.g., malnourished, alcoholics, liver disease).
  • Avoid alcohol consumption during treatment and for several days after discontinuation, as cefoperazone can cause a disulfiram-like reaction (nausea, vomiting, flushing).
  • Administer the medication with caution in patients with gastrointestinal disease, particularly colitis.
  • Complete the full course of therapy to prevent the development of drug-resistant bacteria.

Leave a Reply

Your email address will not be published. Required fields are marked *